Fact CheckerSign in

NCT03520855Completed

Serious Game in the Therapeutic Education of Type 1 Diabetes Paediatric Patients

Contribution of a Serious Game in the Therapeutic Education of Type 1 Diabetes Paediatric Patients

Source: ClinicalTrials.gov · Last updated 31 Mar 2026

Brief summary (registry, in English)

The aim of this study is to evaluate the contribution of a serious game in the reinforcement of knowledge acquired during therapeutic education of type 1 diabetes paediatric patients. This evaluation will take place within 3 months of the diagnosis.

Status (registry)
Completed
Study type
Interventional
Enrollment
78 (actual)
First submitted
27 Apr 2018
Start date
3 Apr 2019
Primary completion date
30 Aug 2023
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT03520855

What you commit to

  • Study type: Interventional
  • Participants enrolled: 78
  • From 3 Apr 2019 to the primary completion date, 30 Aug 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • No internet access or no computer or no tablet or no mobile phone at home available
  • No French language proficiency of the infant or legal representative(s)
  • Inability to understand the game's instructions
  • Inability to understand or fill the consent

Who the study is looking for

  • Child aged from 10 to 17 and 8 months
  • Child with a type 1 diabetes (inclusion within 96 hours following the diagnosis, except for patients admitted to intensive care for whom an additional 48-hour period is accepted for their inclusion). Diagnosis will be confirmed based on one of the classic diagnostic criteria: venous glycaemia above 2 g / l, presence of polyuropolydipsic syndrome, presence of weight loss, presence of ketonuria (equivalent to at least one cross in urine or\> 0.5mmol / l in blood)
  • Child with internet access and with a computer or a tablet or a mobile phone in at least one of the two parents or legal representative(s)
  • Informed consent signed by parents or legal representative(s) (only one parent possible)
  • Beneficiary of a social security system

Age in the registry: 10 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Necker Hospital
Coordinator of this site? Confirm its status
ParisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.